Be Vape-Free school curriculum to prevent teen vaping
Evaluation of the Be Vape Free Curriculum of the Tobacco Prevention Toolkit
This five-session school program teaches middle and high school students about the harms and addictive nature of e-cigarettes to help prevent and reduce vaping.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11170714 on NIH RePORTER |
What this research studies
As a middle or high school student, I would take the Be Vape-Free curriculum during five classroom lessons that explain how e-cigarettes work, why they can be harmful, and how marketing and flavors can be misleading. The lessons were developed with community input and use the most effective pieces of the Tobacco Prevention Toolkit already used by many schools. In the project, groups of schools are compared so some schools deliver the new curriculum while others continue usual health education to see differences in vaping knowledge, attitudes, and behaviors. Teachers deliver the lessons in class and researchers follow up with students to track changes over time.
Who could benefit from this research
Good fit: Ideal participants are middle and high school students (about ages 11–18) who attend participating schools, especially those who have tried or are at risk of trying e-cigarettes.
Not a fit: Adults, children outside the target age range, students at nonparticipating schools, and teens with long-standing nicotine dependence who require clinical cessation treatment may not receive direct benefit from this curriculum alone.
Why it matters
Potential benefit: If successful, this program could lower teen vaping rates, reduce nicotine addiction, and improve adolescent physical and mental health.
How similar studies have performed: Previous school-based tobacco programs have had mixed results and rarely targeted e-cigarettes specifically, so this curriculum combines proven toolkit elements but applies them directly to vaping.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Halpern-Felsher, Bonnie L — Stanford University
- Study coordinator: Halpern-Felsher, Bonnie L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.